Raised serum nitrate and nitrite levels in patients with multiple sclerosis

Journal of the Neurological Sciences

Volumn 145, Issue 1, 1997, Pages 77-81

  Giovannoni, G ^a,b   Heales, S J R ^a   Silver, N C ^b   O'Riordan, J ^b   Miller, R F ^c   Land, J M ^a,b   Clark, J B ^b   Thompson, E J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

AIDS; HIV 1; multiple sclerosis; nitrate; nitric oxide; nitrite; serum

Indexed keywords

NITRATE; NITRITE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; FEMALE; HIV-1; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; NITRATES; NITRITES;

EID: 0030893269     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00246-8     Document Type: Article

References (21)

1. Bagasra, O., Michaels, F.H., Zheng Y.M., Bobroski, L.E., Spitsin, S.V., Fang, Z., Tawadros, R., Koprowski, H. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA., 92: 12041-12045.
2. Barker, J.E., Bolaños, J.P., Land, J.M., Clark, J.B., Heales, S.J.R. (1996) Gluthathione protects astrocytes from peroxynitrite mediated mitochondrial damage. Implications for neuronal/astrocytic trafficking and neurodegeneration. Dev. Neurosci., in press.
3. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA., 87: 1620-1624.
4. Bö, L., Dawson, T.M., Wesselingh, S., Mörk, S., Choi, S., Kong, P.A., Hanley, D., Trapp, B.D., (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol., 36: 778-786.
5. Boje, K.M., Arora, K., (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain. Res., 587: 250-256.
6. Bolaños, J.P., Heales, S.J.R., Land, J.M., Clark, J.B., (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem., 64: 1965-1972.
7. Cross, A.H., Misko, T.P., Lin, R.F., Hickey, W.F., Trotter, J.L., Tilton, R.G., (1994) Aminoguanidine, an inhibitor of inducible nitric-oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest., 93: 2684-2690.
8. Hartung, H-P., Archelos, J.J., Zielasek, J., Gold, R., Koltzenburg, M., Reiners, K-H., Toyka, K.V. (1995) Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology, 45 (suppl. 6): S22-32.
9. Hevel, J.M., Marietta, M.A. (1994) Nitric-oxide synthase assays. Methods Enzymol., 233: 250-258.
10. Inoue, S., Kawanishi, S. (1995) Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS. Lett., 371: 86-88.
11. Johnson, A.W., Land, J.M., Thompson, E.J., Bolanos, J.P., Clark, J.B., Heales, S.R. (1995) Evidence for increased nitric oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry, 58: 107.
12. Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology, 33: 1444-1452.
13. Mackenzie-Graham, A.J., Mitrovic, B., Smoll, A., Merrill, J.E. (1994) Differential sensitivity to nitric oxide in immortalised, cloned murine oligodendrocyte cell lines. Dev. Neurosci., 16: 162-171.
14. Merrill, J.E., Ignarro, L.J., Sherman, M.P., Melinek, J., Lane, T.E. (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol., 51: 2132-2141.
15. Milstien, S., Sakai, N., Brew, B.J., Krieger, C., Vickers, J.H., Saito, K., Heyes, M.P. (1994) Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases. J. Neurochem., 63: 1178-1180.
16. Mitrovic, B., Ignarro, L.J., Montestruque, S., Smoll, A., Merrill, J.E. (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience, 61: 575-585.
17. Moncada, S., Higgs A. (1993) The L-Arginine-Nitric Oxide Pathway. N. Engl. J. Med., 329: 2002-2012.
18. Morrissey, S.P., Miller, D.H., Kendall, B.E., et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 1993; 116: 135-46.
19. Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebners, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H., Tourtellotte, W.W. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol., 13: 227-231.
20. Zangerle, R., Fuchs, D., Reibnegger, G., Werner-Felmayer, G., Gallati, H., Wachter, H., Werner, E.R., (1995) Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1. Immunobiol., 193: 59-70.
21. Zielasek, J., Jung, S., Gold, R., Liew, F.Y., Toyka, K.V., Hartung, H-P., (1995) Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol., 58: 81-88.